Computer Science · Artificial Intelligence
TOWARDS AN EEG-BASED BIOMARKER FOR ALZHEIMER'S DISEASE: IMPROVING AMPLITUDE MODULATION ANALYSIS FEATURES
Francisco J. Fraga, Tiago H. Falk, Lucas R. Trambaiolli, Eliezyer F. Oliveira, Walter H. L, Paulo A. M. K, Renato Anghinah
See on the mapAbstract
In this paper, an EEG-based biomarker for automated Alzheimer’s disease (AD) diagnosis is described, based on extending a recently-proposed “percentage modulation energy ” (PME) metric. More specifically, to improve the signal-to-noise ratio of the EEG signal, PME features were averaged over different durations prior to classification. Additionally, two variants of the PME features were developed: the “percentage raw energy ” (PRE) and the “percentage envelope energy ” (PEE). Experimental results on a dataset of 88 participants (35 controls, 31 with mild-AD and 22 with moderate AD) show that over 98% accuracy can be achieved with a support vector classifier when discriminating between healthy and mild AD patients, thus significantly outperforming the original PME biomarker. Moreover, the proposed system can achieve over 94 % accuracy when discriminating between mild and moderate AD, thus opening doors for very early diagnosis. Index Terms — EEG-based biomarker, Alzheimer’s disease diagnosis, amplitude modulation analysis